Adding Liver-Directed Therapy to Immunotherapy Doubles Survival in Advanced Liver Cancer
A two-center retrospective study found that adding TACE or HAIC to targeted-immunotherapy nearly doubled median overall survival in advanced hepatocellular ...
A two-center retrospective study found that adding TACE or HAIC to targeted-immunotherapy nearly doubled median overall survival in advanced hepatocellular ...
A new review published in Oncoscience argues that the next generation of CAR-T therapy for solid tumors will depend less ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine